Jacques Rouffy

[Case history (purely therapeutic) of insulin resistance].

E Azérad, Jean Lubetzki, Jacques Rouffy, J Laffay et autres

[Double-blind randomized comparative study of nicergoline naftidrofuryl on the quality of life in chronic obliterative arteriopathy of lower limbs with intermittent claudication].

B Meilhac, François Montestruc, François Aubin, F. Djian et autres

The functional limitation of patients with obliterative arterial disease, and with intermittent claudication, damages their quality of life. The purpose of this trial was to compare the effects of nicergoline and naftidrofuryl on the quality of life and the functional discomfort of …

2.P.189 Hyper-HDLemia in renal transplant recipients: Mechanisms and significations

Daniele Erlich, B. Chanu, Yves Goussault, Jeanine Bedrossian et autres

[DIABETES INSIPIDUS INDUCED IN POTOMANICS. CURE BY DECONDITIONING].

Jacques Decourt, M Langer, Jacques Rouffy

Colonic ischemia reveals thromboangiitis obliterans (Buerger's disease)

F. Sauvaget, M Debray, JP Herve de Sigalony, Fichelle Jm et autres

fr (code pays fourni par la source)

[Acute rhabdomyolysis associated with digestive disorders during a voluntary overdose of ciprofibrate].

Olivier Giraud, B. Chanu, D Farge, F Parrot et autres

[Osteitis secondary to toxic dermatitis caused by hydroxyurea. Apropos ofa case, review of the literature].

Nicolas Mounier, Dominique Farge, Célèste Lebbé, Zora Marjanovic et autres

[Double-blind randomized controlled trial of ifenprodil tartrate versus placebo in chronic arterial occlusive disease of the legs at stage II of the Leriche and Fontaine classification].

Alain Branchereau, Jacques Rouffy

Authors report results on a comparative multicenter double blind trial carried out to assess the efficacy of Ifenprodil tartrate (*) (60 mg a.d.) versus placebo in symptomatic treatment of stable peripheral arterial occlusive disease (Fontaine stage II). Ninety four patients were included …

fr (code pays fourni par la source)

[Thromboembolic disease and cancer].

Guy Meyer, D Farge, F. Sauvaget, Jean‐Luc Diehl et autres

Many anomalies in primary haemostasis, coagulation and fibrinolysis have been described which favour thrombosis in cancer patients. Cancer is often associated with other risk factors for thromboembolism which explain much of the increased frequency of thrombosis in these patients. Thromboembolism may precede …

fr (code pays fourni par la source)

Alternative drug therapy of severe hypercholesterolemia: fibrate-statin combination or increased dose of statin?

B. Chanu, C Brestescher, Deborah R. Erlich, Jacques Rouffy

[Tamoxifen and cardiovascular risk].

Dominique Farge, B. Chanu, Philippe M Debourdeau, F. Sauvaget et autres

fr (code pays fourni par la source)

Leucoencéphalopathie multifocale progressive (LEMP) avec infection cérébrale par le virus d'Epstein-Barr (EBV) au cours d'une leucémie lymphoïde chronique (LLC) à localisation cérébrale

Robert Hervé, Dominique Farge, F. Sauvaget, Jacqueline Mikol et autres

fr, be (code pays fourni par la source)